Dr. Osman Bashir Tahir’s career bridges surgical expertise and artistic innovation. His globally recognized techniques, ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

The Tecnis Eyhance IOL yielded positive visual and refractive outcomes in patients with myopia who underwent previous LASIK, ...

Have top stories from The Daily Pennsylvanian delivered to your inbox every day, Monday through Friday, when Penn classes are in session.